Skip to main content
Taylor & Francis Group Logo
    Advanced Search

    Click here to search products using title name,author name and keywords.

    • Login
    • Hi, User  
      • Your Account
      • Logout
      Advanced Search

      Click here to search products using title name,author name and keywords.

      Breadcrumbs Section. Click here to navigate to respective pages.

      Book

      Rapid Revision in Clinical Pharmacology
      loading

      Book

      Rapid Revision in Clinical Pharmacology

      DOI link for Rapid Revision in Clinical Pharmacology

      Rapid Revision in Clinical Pharmacology book

      Rapid Revision in Clinical Pharmacology

      DOI link for Rapid Revision in Clinical Pharmacology

      Rapid Revision in Clinical Pharmacology book

      ByBen Greenstein
      Edition 1st Edition
      First Published 2008
      eBook Published 31 December 2016
      Pub. Location London
      Imprint CRC Press
      DOI https://doi.org/10.1201/9781315376707
      Pages 232
      eBook ISBN 9781315376707
      Subjects Medicine, Dentistry, Nursing & Allied Health
      Share
      Share

      Get Citation

      Greenstein, B. (2008). Rapid Revision in Clinical Pharmacology (1st ed.). CRC Press. https://doi.org/10.1201/9781315376707

      ABSTRACT

      This book addresses the five core components of an investment appraisal; strategic, economic, commercial, financial and project management. It provides managers and policy makers in healthcare, government and private sector organisations with a tried and tested decision making tool and supporting guidance to improve capital investment decisions. It is a practical guide that includes numerous examples from the health service as well as lessons learnt from other public sector areas where best practice has been demonstrated. Comprehensively illustrated with case studies, checklists and templates to aid decision making, it offers practical, evidence-based guidance, clear summaries and pointers to accessing further information.

      TABLE OF CONTENTS

      chapter 1|3 pages

      Introduction

      chapter 2|4 pages

      Pharmacology overview

      chapter 3|6 pages

      Pharmacokinetics

      chapter 4|6 pages

      Pharmacodynamics

      chapter 5|3 pages

      Clinical trials

      chapter 6|5 pages

      Receptors

      chapter 7|3 pages

      The autonomic system I: introduction

      chapter 8|8 pages

      The autonomic system II: parasympathetic division (PNS)

      chapter 9|10 pages

      The autonomic system III: sympathetic division (SNS)

      chapter 10|9 pages

      The neuromuscular junction (NMJ)

      chapter 11|4 pages

      Myasthenia

      chapter 12|7 pages

      5-hydroxytryptamine (5-HT; serotonin)

      chapter 13|3 pages

      Eiconasoids

      chapter 14|5 pages

      Peptides and proteins as drugs (‘biological’ drugs)

      part 15|2 pages

      Systems targeted by drugs

      chapter 16|7 pages

      Diuretics

      chapter 17|7 pages

      Drugs and the heart I: heart failure

      chapter 18|5 pages

      Drugs and the heart II: myocardial infarction (heart attack)

      chapter 19|12 pages

      Drugs and the heart III: antidysrhythmic drugs

      chapter 20|5 pages

      Drugs and the heart IV: angina pectoris

      chapter 21|7 pages

      Drugs and the heart V: antiplatelet drugs

      chapter 22|8 pages

      Anticoagulants I: heparin, hirudins and heparinoids

      chapter 23|6 pages

      Anticoagulants II: oral anticoagulants

      chapter 24|6 pages

      Fibrinolytic and antifi brinolytic drugs

      chapter 25|3 pages

      Hypertension I: introduction

      chapter 26|14 pages

      Hypertension II: treatment

      chapter 27|5 pages

      Infl ammation I: introduction

      chapter 28|5 pages

      Infl ammation II: non-steroidal anti-infl ammatory drugs (NSAIDs), mainly aspirin

      chapter 29|5 pages

      Infl ammation III: steroidal anti-infl ammatory drugs

      chapter 30|5 pages

      Infl ammation IV: disease-modifying anti-rheumatic drugs (DMARDs)

      chapter 31|5 pages

      Infl ammation V: gout, scleroderma and Raynaud’s phenomenon

      chapter 32|6 pages

      Paracetamol (USA: acetaminophen)

      chapter 33|6 pages

      Opioid analgesics

      chapter 34|3 pages

      Local anaesthetics

      chapter 35|5 pages

      General anaesthetics

      chapter 36|6 pages

      Parkinson’s disease

      chapter 37|6 pages

      Epilepsy

      part 38|2 pages

      Alzheimer’s disease

      chapter 39|5 pages

      Antidepressant drugs

      chapter 40|3 pages

      Anxiolytic drugs

      chapter 41|5 pages

      Anti-infective drugs (antibiotics)

      chapter 42|6 pages

      Chemotherapy for malignancy (cancer)

      T&F logoTaylor & Francis Group logo
      • Policies
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
        • Privacy Policy
        • Terms & Conditions
        • Cookie Policy
      • Journals
        • Taylor & Francis Online
        • CogentOA
        • Taylor & Francis Online
        • CogentOA
      • Corporate
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
        • Taylor & Francis Group
      • Help & Contact
        • Students/Researchers
        • Librarians/Institutions
        • Students/Researchers
        • Librarians/Institutions
      • Connect with us

      Connect with us

      Registered in England & Wales No. 3099067
      5 Howick Place | London | SW1P 1WG © 2022 Informa UK Limited